Best treatments for transitional cell carcinoma
3 products may treat transitional cell carcinoma, spanning FDA drug classes such as programmed death ligand-1 blocker. The current highest-rated option is bavencio. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for transitional cell carcinoma, none are yet flagged as generics in our price data, spanning classes such as programmed death ligand-1 blocker. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for transitional cell carcinoma — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Injectable | Programmed Death Ligand-1 Blocker | No data | — | View → | |
| 2 | Not yet rated | Prescription | Tablet | — | No data | — | View → | |
| 3 | Not yet rated | Prescription | Injectable | Programmed Death Ligand-1 Blocker | No data | — | View → |
Narrow by drug class
Explore the class hubs: programmed death ligand-1 blocker
Full ranking · 3 treatments
bavencio
PrescriptionFDA-sourced
Bavencio (Avelumab) is a programmed death ligand-1 blocker used to treat Transitional Cell Carcinoma, Merkel Cell Carcinoma.
Price varies
balversa
PrescriptionFDA-sourced
Balversa (Erdafitinib) is a medication used to treat Transitional Cell Carcinoma.
Price varies
imfinzi
PrescriptionFDA-sourced
Imfinzi (Durvalumab) is a programmed death ligand-1 blocker used to treat Transitional Cell Carcinoma.
Price varies
Frequently asked
- What treats transitional cell carcinoma?
- Our catalog lists 3 products that may treat transitional cell carcinoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is bavencio.
- What is the best-rated treatment for transitional cell carcinoma?
- By our independent recall-safety rating — not an efficacy measure — bavencio ranks highest among the products we list for transitional cell carcinoma. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat transitional cell carcinoma?
- Treatments for transitional cell carcinoma span FDA drug classes including programmed death ligand-1 blocker. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.